Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain metastases.

Teri D Nguyen1, Lisa M DeAngelis

  • 1Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

Neurologic Clinics
|October 30, 2007
PubMed
Summary
This summary is machine-generated.

Brain metastases significantly impact cancer patient management and outcomes. Optimizing supportive care alongside definitive treatments is crucial for managing symptoms and improving quality of life.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Classification and Management of Ischemic Stroke in Patients With Active Cancer: A Scientific Statement From the American Heart Association.

Stroke·2026
Same author

Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine for newly diagnosed primary CNS lymphoma.

Neuro-oncology·2026
Same author

Multicenter randomized phase II study of R-MPV-A chemoimmunotherapy with or without low-dose whole-brain radiotherapy for newly-diagnosed primary CNS lymphoma.

Neuro-oncology·2025
Same author

Prospective characterization of germline variants in patients with gliomas and glioneuronal tumors.

Acta neuropathologica·2025
Same author

Multicenter basket trial for central nervous system tumors identifies activity of the CDK4/6 inhibitor abemaciclib in recurrent meningioma.

Neuro-oncology·2025
Same author

Phase Ib study with expansion of ibrutinib, lenalidomide, and rituximab in patients with relapsed/refractory central nervous system lymphoma.

Neuro-oncology·2025
Same journal

Sports Neurology.

Neurologic clinics·2026
Same journal

Sports-Related Peripheral Nerve Injuries.

Neurologic clinics·2026
Same journal

Active Rehabilitation and Return to Play in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Autonomic Assessment and Management in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Management of Vestibular Symptoms in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Neuropsychological Assessment in Sport-Related Concussion: Evidence, Controversies, and Clinical Applications.

Neurologic clinics·2026
See all related articles

Area of Science:

  • Oncology
  • Neurology

Background:

  • Brain metastases are a frequent complication of cancer.
  • They significantly influence patient management compared to other metastatic sites.

Purpose of the Study:

  • To review the management of brain metastases.
  • To emphasize the importance of supportive therapies in conjunction with definitive treatments.

Main Methods:

  • Review of current therapeutic strategies for brain metastases.
  • Discussion of factors influencing treatment choices and prognosis.

Main Results:

  • Supportive therapies (steroids, antiseizure medications) are essential for symptom amelioration.
  • Definitive treatments include radiation, surgery, and chemotherapy.

Related Experiment Videos

  • Treatment selection and prognosis depend on patient factors and disease characteristics.

    • Conclusions:

    • Optimizing supportive care is vital for maintaining patient quality of life.
    • Further investigation into definitive treatment strategies is ongoing.
    • Reducing neurological death and disability are key therapeutic goals.